Pine River Capital Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-9,039
Closed -$715K 408
2016
Q3
$715K Buy
+9,039
New +$734K 0.01% 359
2016
Q2
Sell
-13,100
Closed -$1.2M 474
2016
Q1
$1.2M Buy
+13,100
New +$1.18M 0.02% 293
2015
Q4
Sell
-5,100
Closed -$501K 692
2015
Q3
$501K Buy
+5,100
New +$566K 0.01% 522
2015
Q1
Sell
-61,393
Closed -$5.79M 681
2014
Q4
$5.79M Buy
61,393
+59,193
+2,691% +$6.12M 0.07% 181
2014
Q3
$234K Buy
+2,200
New +$215K ﹤0.01% 908
2014
Q2
Sell
-142,500
Closed -$11.1M 730
2014
Q1
$10.1M Buy
+142,500
New +$11.2M 0.15% 160
2013
Q3
Sell
-14,913
Closed -$891K 499
2013
Q2
$765K Buy
+14,913
New +$777K 0.01% 387

Other funds holding GILD

Pine River Capital Management's GILD Position: Q4 2016 in Review

Pine River Capital Management sold out of Gilead Sciences (GILD) in Q4 2016, closing a stake of 9,039 shares — an estimated $715K sold.

Pine River Capital Management first reported a position in GILD in Q2 2013 and held it in 7 quarters. The position peaked at $10.1M in Q1 2014. 1,572 funds tracked by Wall St. Rank hold GILD as of Q4 2016.

  • Pine River Capital Management reported no remaining Gilead Sciences position as of Q4 2016 after selling out during the quarter.
  • Pine River Capital Management sold 9,039 Gilead Sciences shares in Q4 2016, an estimated $715K.
  • Pine River Capital Management first reported a position in Gilead Sciences in Q2 2013 and held it in 7 quarters.
  • Pine River Capital Management's Gilead Sciences position peaked at $10.1M in Q1 2014.
  • 1,572 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2016.

Based on Pine River Capital Management's 13F filing for Q4 2016, filed 14 Feb 2017.